The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The association of epidermal growth factor receptor (EGFR) mutation and survival in N2(+) non-small cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy.
H. K. Ahn
No relevant relationships to disclose
Y. L. Choi
No relevant relationships to disclose
J. Sun
No relevant relationships to disclose
Y. C. Ahn
No relevant relationships to disclose
K. Kim
No relevant relationships to disclose
J. Kim
No relevant relationships to disclose
Y. M. Shim
No relevant relationships to disclose
J. S. Ahn
No relevant relationships to disclose
K. Park
No relevant relationships to disclose
M. Ahn
No relevant relationships to disclose